Origin Agritech Stock Price, News & Analysis

Origin Agritech Ltd. (NASDAQ: SEED) announced its participation in Benchmark's Discovery One on One Conference on December 2, 2021. This unique format allows individual meetings with various institutional investors, with attendance typically exceeding 150 investors. VP of Business Development, Wei Han, highlighted China's shift toward GMO positivity as an important opportunity for the company. Origin Agritech, a leading agricultural technology firm based in Beijing, specializes in crop seed biotechnologies, including glyphosate-resistant and pest-resistant traits.

Origin Agritech Ltd. (NASDAQ: SEED) announced progress on its new GMO corn trait, successfully completing environmental release trials and moving into production trials, the fourth stage in the bio-safety certification process. Developed with the Chinese Academy of Agricultural Sciences, this trait offers enhanced pest resistance compared to existing options, positioning the company competitively in the GMO corn market. VP Wei Han emphasized its importance for food security in China and its potential to reduce reliance on harmful insecticides.

Origin Agritech Ltd. (NASDAQ: SEED) announced applying for plant variety protection for 13 new hybrid corn varieties, adding to 4 previously approved. Despite adverse weather impacting the corn harvest in northern China, Origin's hybrids show significant disease tolerance and yield improvements. The company anticipates strong demand for these new products, expected for pre-order by spring 2022. Chairman Dr. Gengchen Han emphasized the importance of high-quality seeds in challenging growing conditions, highlighting future revenue potential tied to their germplasm bank efforts.

Origin Agritech Ltd. (NASDAQ: SEED) announced a collaboration with China Agricultural University focused on using CRISPR gene editing for corn crop innovation. This partnership aims to enhance genetic advancements for improved yield and nutritional value. Origin's existing CRISPR platform has yielded breakthroughs in drought resistance and nutritional traits. CEO Dr. Gengchen Han emphasized that this collaboration will strengthen Origin's technological leadership and contribute to China's agricultural advancements.

Origin Agritech Ltd. (NASDAQ: SEED) has appointed PCG Advisory, Inc. as its new investor relations firm. This collaboration aims to enhance the company's marketing strategies to a broader investment community amidst China's agricultural modernization efforts. Dr. Gengchen Han, the Chairman, highlighted the critical role Origin will play in this initiative. PCG Advisory's CEO, Jeff Ramson, expressed enthusiasm about promoting Origin's compelling investment story, targeting both agriculture technology and growth investors.

Origin Agritech Ltd. (NASDAQ: SEED) has entered an exclusive rights agreement with the Biology Research Institute of the Chinese Academy of Agricultural Sciences for a drought-resistant GMO trait. The agreement grants Origin global rights to the trait, which has shown a yield increase of 9.2-16.2% over non-GMO corn in water-stressed conditions and improved water use efficiency by 33-47% under irrigated conditions. The Ministry of Agriculture has approved the trait for production trials, marking a significant step towards commercialization. This development aligns with the growing focus on drought resistance amid climate change.

Origin Agritech Ltd. (NASDAQ: SEED) has received approval from the Ministry of Agriculture and Rural Affairs in China for four new hybrid corn breeds. This approval enhances the company's product pipeline and competitiveness in China's corn seed market. Origin is also working on GMO-enhanced versions of these hybrids, further streamlining the approval process. Dr. Gengchen Han, Chairman of Origin Agritech, expressed optimism about expanding germplasm resources to support the development of GMO hybrid seeds.

Origin Agritech Ltd. (NASDAQ: SEED) announced significant progress in the official government trials of GMO corn hybrid varieties. One herbicide-resistant variety has completed its final trial and awaits approval, while five double-stack GMO corn hybrids have moved to the second-year trials. Additionally, three new hybrids are set for first-year trials next year, totaling 27 hybrids at various evaluation stages. Thirteen GMO Phytase varieties are also pending final approval. The company emphasizes the importance of these developments for future market readiness.

Origin Agritech Ltd. (NASDAQ: SEED) announced that Chairman Dr. Gengchen Han was interviewed by The Wall Street Resource Podcast. The discussion highlighted the company's significant investments in research, positioning it to benefit from China's expected approval of GMO crops, a market estimated to be worth billions. Dr. Han emphasized that this opportunity is primarily reserved for domestic firms. Origin Agritech has pioneered various biotech seeds and continues to develop a strong product pipeline, contributing to its competitive advantage in the agricultural sector.